Cargando…

N‐nitrosodimethylamine‐Contaminated Valsartan and Risk of Cancer: A Nationwide Study of 1.4 Million Valsartan Users

BACKGROUND: Since July 2018, numerous lots of valsartan have been found to be contaminated with N‐nitrosodimethylamine (NDMA). We aimed to assess the association between exposure to valsartan products contaminated with NDMA and the risk of cancer. METHODS AND RESULTS: This study was based on data fr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mansouri, Imène, Botton, Jeremie, Semenzato, Laura, Haddy, Nadia, Zureik, Mahmoud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798794/ https://www.ncbi.nlm.nih.gov/pubmed/36533625 http://dx.doi.org/10.1161/JAHA.122.026739

Ejemplares similares

Use of N-nitrosodimethylamine (NDMA) contaminated valsartan products and risk of cancer: Danish nationwide cohort study
por: Pottegård, Anton, et al.
Publicado: (2018)

Rapid and efficient high-performance liquid chromatography analysis of N-nitrosodimethylamine impurity in valsartan drug substance and its products
por: Masada, Sayaka, et al.
Publicado: (2019)

N-Nitrosodimethylamine Contamination in the Metformin Finished Products
por: Zmysłowski, Adam, et al.
Publicado: (2020)

N-Nitrosodimethylamine
por: Liteplo, R. G.

No association of low‐dose aspirin with severe COVID‐19 in France: A cohort of 31.1 million people without cardiovascular disease
por: Botton, Jérémie, et al.
Publicado: (2022)

Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people
por: Semenzato, Laura, et al.
Publicado: (2021)

Sacubitril/Valsartan Conundrum
por: Somberg, John
Publicado: (2021)

Effect of sacubitril/valsartan or valsartan on ventricular remodeling and myocardial fibrosis in perimenopausal women with hypertension
por: Chen, Jianshu, et al.
Publicado: (2023)

Simultaneous Determination of Amlodipine and Valsartan
por: Mohamed, Nashwah Gadallah
Publicado: (2011)

N-nitrosodimethylamine (NDMA) contamination of ranitidine products: A review of recent findings
por: Aldawsari, Fahad S., et al.
Publicado: (2021)

Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients
por: Semenzato, Laura, et al.
Publicado: (2021)

Real-world effectiveness of amlodipine/valsartan and amlodipine/valsartan/hydrochlorothiazide in high-risk patients and other subgroups
por: Assaad-Khalil, Samir Helmy, et al.
Publicado: (2015)

Efficacy and safety of sacubitril/valsartan vs. valsartan in patients with acute myocardial infarction: A meta-analysis
por: Yang, Pei, et al.
Publicado: (2022)

Risk of Cancer Following the Use of N-Nitrosodimethylamine (NDMA) Contaminated Ranitidine Products: A Nationwide Cohort Study in South Korea
por: Yoon, Hong Jin, et al.
Publicado: (2021)

Valsartan in the Treatment of Heart Attack Survivors
por: Jugdutt, Bodh I
Publicado: (2006)

Implication of low dose sacubitril/valsartan
por: Imamura, Teruhiko
Publicado: (2021)

Eligibility and Usage of Sacubitril/Valsartan in Korea
por: Kim, Jin-Jin, et al.
Publicado: (2019)

To compare anti-albumin urea effects of valsartan alone with combination of valsartan and amlodipine in patients of chronic kidney disease
por: Ameen,, et al.
Publicado: (2016)

Efficacy and Safety of Valsartan or Chlorthalidone vs. Combined Valsartan and Chlorthalidone in Patients With Mild to Moderate Hypertension: The VACLOR Study
por: Manzur, Fernando, et al.
Publicado: (2018)

Comparative and Combinatorial Effects of Resveratrol and Sacubitril/Valsartan alongside Valsartan on Cardiac Remodeling and Dysfunction in MI-Induced Rats
por: Raj, Pema, et al.
Publicado: (2021)

Study of the possible effect of sacubitril/valsartan combination versus valsartan on the cognitive function in Alzheimer’s disease model in rats
por: El-din Hussein, Abdallah Salah, et al.
Publicado: (2023)

Reduced risk of severe COVID-19 in more than 1.4 million elderly people aged 75 years and older vaccinated with mRNA-based vaccines
por: Botton, Jérémie, et al.
Publicado: (2022)

Association of Statins for Primary Prevention of Cardiovascular Diseases With Hospitalization for COVID‐19: A Nationwide Matched Population‐Based Cohort Study
por: Bouillon, Kim, et al.
Publicado: (2022)

Efficacies of Controlling Morning Blood Pressure and Protecting the Kidneys by Treatment With Valsartan and Nifedipine CR or Valsartan and Amlodipine (MONICA Study)
por: Tanaka, Tohru, et al.
Publicado: (2013)

Characteristics associated with the residual risk of severe COVID-19 after a complete vaccination schedule: A cohort study of 28 million people in France
por: Semenzato, Laura, et al.
Publicado: (2022)

Optimal timing for antihypertensive dosing: focus on valsartan
por: Hermida, Ramón C, et al.
Publicado: (2007)

Aliskiren and valsartan combination therapy for the management of hypertension
por: Epstein, Benjamin J
Publicado: (2010)

Influence of valsartan-eluting stent on neointima formation
por: Guihua, Li, et al.
Publicado: (2010)

Insights into implementation of sacubitril/valsartan into clinical practice
por: Martens, Pieter, et al.
Publicado: (2018)

Sacubitril–valsartan in heart failure and multimorbidity patients
por: Rodil Fraile, Raquel, et al.
Publicado: (2018)

Indoxyl sulfate impairs valsartan-induced neovascularization()
por: Kuo, Ko-Lin, et al.
Publicado: (2020)

Re: Implication of low‐dose sacubitril/valsartan
por: Pandey, Amitabh C., et al.
Publicado: (2021)

Effects of valsartan on morphine tolerance and dependence in rats
por: Kaeidi, Ayat, et al.
Publicado: (2021)

Impact of national valsartan recalls on Veterans’ outcomes
por: Morizio, Paige L., et al.
Publicado: (2021)

Molecular mechanisms of sacubitril/valsartan in cardiac remodeling
por: Mustafa, Nor Hidayah, et al.
Publicado: (2022)

Effects of Sacubitril/Valsartan on the Renal Resistance Index
por: Gioia, Margherita Ilaria, et al.
Publicado: (2022)

The Occurrence of N-nitrosodimethylamine (NDMA) in Swimming Pools: An Overview
por: Mustapha, Saheed, et al.
Publicado: (2021)

Higher persistence with valsartan compared with enalapril in daily practice
por: Siiskonen, Satu J, et al.
Publicado: (2007)

Clinical utility of valsartan in the treatment of hypertension in children and adolescents
por: Baracco, Rossana, et al.
Publicado: (2011)

Simultaneous Determination of Valsartan and Hydrochlorothiazide in Tablets by RP-HPLC
por: Tian, D. F., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_ts6u33aolnl42mevkmduf2l6bv